Regenerative Medical Technology Group Inc. Stock-Based Compensation
Regenerative Medical Technology Group Inc. (RMTG) reported Stock-Based Compensation of $400 for the 6-month period ending 2020-06-30, per its 10-Q filed 2021-02-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-04-13
- Regenerative Medical Technology Group Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-06-30 was $200.00, a 0.00% change year-over-year.
- Regenerative Medical Technology Group Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $200.00, a 0.00% change year-over-year.
- Regenerative Medical Technology Group Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $200.00.
- Regenerative Medical Technology Group Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $200.00.
- Regenerative Medical Technology Group Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $1.16M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|
| 2020-06-30 | $200.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $400.00 10-Q · filed 2021-02-08 | |
| 2020-03-31 | $200.00 10-Q · filed 2021-01-07 | ||
| 2019-12-31 | $1.16M 10-K · filed 2021-04-13 | ||
| 2019-06-30 | $200.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $400.00 10-Q · filed 2021-02-08 | |
| 2019-03-31 | $200.00 10-Q · filed 2021-01-07 |